Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.
Viewing Page 5 of 22 | Showing Results 21 - 25 of 108

I3Y-MC-JPCF/B-58A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer

The purpose of the study is to determine if administration of the investigational drug, abemaciclib, in addition to adjuvant endocrine therapy...

Stavroula Otis, M.D.
  • xSJH Southern California

NSABP PROTOCOL B-51/RTOG PROTOCOL 1304 - A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

The main purpose of this clinical trial is to study women like you who have cancer cells in the lymph nodes at the time that the breast cancer is...

Peter Chen, M.D.
  • Hoag Research
  • xSJH Southern California

NSABP B-51: A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

This randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have...

David Margileth, M.D.
  • St. Joseph Hospital of Orange
  • xSJH Southern California

DFC AMG 20110203 GALACTIC-HF-A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)

Key Inclusion Criteria:•Male or female, ≥ 18 to ≤ 85 years•History of chronic HF (defined as requiring treatment for HF for a minimum of 30 days...

Daniel Eisenberg, M.D.
  • PMI Cardiology - DO NOT USE
  • Providence Los Angeles Research Center
  • Providence St. Joseph Medical Center (PSJMC)

TANGO: Temsirolimus adventitial delivery to improve angiographic outcomes below the knee

This is a prospective, multi-center, randomized, dose escalation study to document the effects of adventitial delivery of temsirolimus (Torisel)...

Mahmood Razavi, M.D.
  • St. Joseph Hospital of Orange
  • xSJH Southern California
Viewing Page 5 of 22 | Showing Results 21 - 25 of 108